Andrew Robbins
2021
In 2021, Andrew Robbins earned a total compensation of $2.9M as Chief Executive Officer at Cogent Biosciences, a 84% decrease compared to previous year.
Compensation breakdown
| Bonus | $357,075 |
|---|---|
| Option Awards | $1,901,555 |
| Salary | $592,648 |
| Other | $11,600 |
| Total | $2,862,878 |
Robbins received $1.9M in option awards, accounting for 66% of the total pay in 2021.
Robbins also received $357.1K in bonus, $592.6K in salary and $11.6K in other compensation.
Rankings
In 2021, Andrew Robbins' compensation ranked 4,618th out of 12,415 executives tracked by ExecPay. In other words, Robbins earned more than 62.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,618 out of 12,415 | 63rd |
Division Manufacturing | 1,915 out of 5,505 | 65th |
Major group Chemicals And Allied Products | 800 out of 2,375 | 66th |
Industry group Drugs | 714 out of 2,096 | 66th |
Industry Pharmaceutical Preparations | 508 out of 1,546 | 67th |
Source: SEC filing on April 26, 2022.
Robbins' colleagues
We found two more compensation records of executives who worked with Andrew Robbins at Cogent Biosciences in 2021.